Overview of current management of sleep disturbances in children: I - Pharmacotherapy

Current Therapeutic Research - Clinical and Experimental

Volumn 63, Issue SUPPL. B, 2002, Pages

  Reed, Michael D ^a   Findling, Robert L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Hypnotic; Insomnia; Pediatric; Sedative; Sleep; Sleep disturbance; Soporific

Indexed keywords

ALIMEMAZINE; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BROMPHENIRAMINE; CARBINOXAMINE MALEATE; CHLORAL HYDRATE; CLEMASTINE FUMARATE; CLONAZEPAM; CLONIDINE; CLORAZEPATE; DIAZEPAM; DIMENHYDRINATE; DIPHENHYDRAMINE; ESTAZOLAM; FLURAZEPAM; HYDROXYZINE; HYPNOTIC AGENT; IMIPRAMINE; MECLOZINE; MELATONIN; OXAZEPAM; PHENOTHIAZINE DERIVATIVE; PROMETHAZINE; QUAZEPAM; SEDATIVE AGENT; TEMAZEPAM; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLPIDEM;

ANTEROGRADE AMNESIA; CENTRAL NERVOUS SYSTEM DEPRESSION; CHILDHOOD DISEASE; CLINICAL PHARMACOLOGY; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HUMAN; INSOMNIA; LETHARGY; MALAISE; MOOD; NARCOLEPSY; NIGHTMARE; NOCTURNAL ENURESIS; PHOTOPHOBIA; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RESPIRATION DEPRESSION; SEDATION; SEIZURE; SLEEP DISORDER; XEROSTOMIA;

EID: 0036304485     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(02)80101-1     Document Type: Conference Paper

References (69)

1. Pediatric psychopharmacology: A review of recent research
2. The pharmacologic treatment of sleep disorders
3. Pharmacologic treatment of psychiatry and neurodevelopmental disorders in children and adolescents (Part 1)
4. Snoring, sleep disturbance, and behaviour in 4-5 year olds
5. Children and nocturnal snoring: Evaluation of the effects of sleep related respiratory resistive and daytime functioning
6. Neurophysiological features and differential diagnosis of sleep apnea syndrome in children
7. Neuropsychological sequelae of obstructive sleep apnea in children
8. Cognitive function following acute sleep restriction in children ages 10-14
9. Cosleeping in urban families with young children in the United States
10. Sleep problems in early childhood: Continuities, predictive factors, and behavioral correlates
11. Persistence of sleep disturbances in preschool children
12. The first-born child: Patterns of development
13. Insomnia in the child and adolescent
14. Psychopharmacology in child and adolescent psychiatry: A review of the past seven years. Part II
15. Drugs and the treatment of psychiatric disorders: Psychosis and anxiety
16. Meta-analysis of benzodiazepine use in the treatment of insomnia
17. Developmental features of sleep
18. Sleep disorders in children
19. Diazepam (Valium) treatment in childhood sleep disorders: A preliminary investigation
20. Pharmacological treatment of insomnia
21. The diagnosis and management of insomnia
22. Drugs used for the treatment of anxiety and sleep disorders
23. Management of insomnia
24. Barbiturate and nonbarbiturate sedative hypnotic intoxication in children
25. Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials
26. The diagnosis and management of insomnia in clinical practice: A practical evidence-based approach
27. Adverse reactions to benzodiazepine hypnotics: Spontaneous reporting system
28. Hypnotic drugs and their effectiveness. All-night EEG studies of insomniac subjects
29. Diagnosis and treatment of insomnia in the elderly
30. Chloral hydrate use during infancy
31. Chloral hydrate
32. Clinical pharmacokinetics of hypnotics
33. Chloral hydrate disposition following single-dose administration to critically ill neonates and children
34. Adverse events and risk factors associated with the sedation of children by nonanesthesiologists
35. Chloral hydrate: A risky old psychotropic drug
36. Adverse sedation events in pediatrics: Analysis of medications used for sedation
37. Chloral hydrate: The good and the bad
38. Histamine, bradykinin, and their antagonists
39. The effectiveness of diphenhydramine HCl in pediatric sleep disorders
40. Sleep problems in childhood
41. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists
42. Clonidine for sleep disturbances associated with attention deficit hyperactivity disorder
43. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: A systematic chart review of 62 cases
44. Catecholamines and the sympathomimetic drugs
45. Combining methylphenidate and clonidine: Pharmacologic questions and news reports about sudden death
46. Clonidine overdose in childhood: Implications of increased prescribing
47. The therapeutics of melatonin: A paediatric perspective
48. Melatonin treatment in an institutionalised child with psychomotor retardation and an irregular sleep-wake pattern
49. Effects of a low dose of melatonin on sleep in children with Angelman syndrome
50. Sleep dysfunction in Rett syndrome: A trial of exogenous melatonin treatment
51. Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome
52. The use of melatonin to treat sleep-wake-rhythm disorders in children who are visually impaired
53. Long-term melatonin treatment in blind children and young adults with circadian sleep-wake disturbances
54. Melatonin: A clinical perspective
55. Melatonin treatment of chronic sleep disorders
56. Use of melatonin in the treatment of paediatric sleep disorders
57. The safety and tolerability of zolpideman update
58. Enuresis treatment with imipramine hydrochloride: A 10-year follow-up study
59. Treatment issues related to sleep and depression
60. Treatment of infant sleep disturbance by trimeprazine in combination with extinction
61. A double-blind drug trial of treatment in young children with waking problems
62. Controlled trial of trimeprazine tartrate for night waking
63. The effect of niaprazine on some common sleep disorders in children. A double-blind clinical trial by means of continuous home video-recorded sleep
64. Comparison of niaprazine and placebo in pediatric behaviour and sleep disorders: Double-blind clinical trial